You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

515 Results
Guidelines and Advice
Status: Current
ID: GL-C50-32
Jan 2021
Symptom Management
Drug
Other Name(s): Navelbine®
Apr 2023
Drug
Other Name(s): Votrient®
Dec 2024
Drug
Other Name(s): Oncovin® (multiple brands available)
Nov 2017
Drug
Other Name(s): Neulasta®, Lapelga®, Fulphila™; Ziextenzo®; Nyvepria™, Niopeg®, Pexegra™
Sep 2025
Drug
Other Name(s): Alimta®
Apr 2023
Drug
Mar 2021
Drug
Feb 2024

Pages